16 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Oct 15
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate Development Officer
12:00am
to the newly-created position of Chief Corporate Development Officer (CCDO). Ms. Stevens will be a member of BioBlast’s Executive Committee and will oversee
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
multiple sources, including the Company’s personnel who oversee the pre-clinical and clinical trial activities, information from service providers
20-F/A
2018 FY
ENLV
Enlivex Therapeutics Ltd
23 Jan 20
Annual report (foreign) (amended)
4:31pm
and oversee over our business. Our Board of Directors may exercise all powers and may take all actions that are not specifically granted to our
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
of Bioblast;
the CVR Agreement will enable the Bioblast shareholder representative to oversee the licensing or sale of the Trehalose assets … to the Chairman, or otherwise.
BOARD OF DIRECTORS
Powers of Board of Directors
The Board of Directors shall determine the Company’s policies, oversee
20-F
771o6mx b51681o
31 Mar 15
Annual report (foreign)
12:00am
F-1/A
4bvung oa2v9uu6o
8 Jul 14
Registration statement (foreign) (amended)
12:00am
424B4
6lh3vzws2a2n jd0
31 Jul 14
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next